Value of 2-[¹⁸F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review

Sambavy Nadaraja^*, Jonas Helsing, Mohammad Naghavi-Bezhad, Lotte H. Land, Christina H. Ruhlmann, Oke Gerke, Malene G. Hildebrandt

^*Corresponding author for this work

Odense University Hospital

Research output: Contribution to journal › Journal article › Research › peer-review

1 Comment/debate

1 results

Filter

2024
Correction to: Value of 2-[18F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review (Clinical and Translational Imaging, (2024), 12, 2, (187-195), 10.1007/s40336-024-00618-3)
Nadaraja, S., Helsing, J., Naghavi-Behzad, M., Land, L. H., Ruhlmann, C. H., Gerke, O. & Hildebrandt, M. G., Jun 2024, In: Clinical and Translational Imaging. 12, 3, p. 373 1 p.
Research output: Contribution to journal › Comment/debate › Research › peer-review